EyePoint Pharmaceuticals Inc (EYPT)
18.00
+1.05
(+6.19%)
USD |
NASDAQ |
Apr 23, 13:41
EyePoint Pharmaceuticals 1 Year Total Returns (Daily): 88.33% for April 22, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 22, 2024 | 88.33% |
April 19, 2024 | 227.5% |
April 18, 2024 | 255.7% |
April 17, 2024 | 331.8% |
April 16, 2024 | 404.4% |
April 15, 2024 | 391.5% |
April 12, 2024 | 570.1% |
April 11, 2024 | 573.2% |
April 10, 2024 | 553.9% |
April 09, 2024 | 560.4% |
April 08, 2024 | 535.9% |
April 05, 2024 | 570.4% |
April 04, 2024 | 521.0% |
April 03, 2024 | 558.7% |
April 02, 2024 | 589.8% |
April 01, 2024 | 589.5% |
March 28, 2024 | 625.3% |
March 27, 2024 | 635.3% |
March 26, 2024 | 804.8% |
March 25, 2024 | 851.3% |
March 22, 2024 | 831.4% |
March 21, 2024 | 820.2% |
March 20, 2024 | 860.9% |
March 19, 2024 | 840.4% |
March 18, 2024 | 806.4% |
Date | Value |
---|---|
March 15, 2024 | 798.7% |
March 14, 2024 | 762.7% |
March 13, 2024 | 759.5% |
March 12, 2024 | 842.6% |
March 11, 2024 | 845.0% |
March 08, 2024 | 763.7% |
March 07, 2024 | 706.1% |
March 06, 2024 | 694.4% |
March 05, 2024 | 684.4% |
March 04, 2024 | 694.8% |
March 01, 2024 | 783.3% |
February 29, 2024 | 714.7% |
February 28, 2024 | 728.7% |
February 27, 2024 | 750.7% |
February 26, 2024 | 709.5% |
February 23, 2024 | 658.4% |
February 22, 2024 | 603.5% |
February 21, 2024 | 652.3% |
February 20, 2024 | 703.0% |
February 16, 2024 | 696.3% |
February 15, 2024 | 685.9% |
February 14, 2024 | 649.2% |
February 13, 2024 | 626.2% |
February 12, 2024 | 631.8% |
February 09, 2024 | 590.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-84.03%
Minimum
Nov 03 2020
860.9%
Maximum
Mar 20 2024
37.03%
Average
-18.16%
Median
Jun 22 2023
1 Year Total Returns (Daily) Benchmarks
INVO Bioscience Inc | -86.01% |
Bio-Path Holdings Inc | -89.43% |
Ocular Therapeutix Inc | -21.07% |
Aileron Therapeutics Inc | 213.3% |
Apellis Pharmaceuticals Inc | -44.77% |